UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of naproxen co-administration on valproate disposition

Biopharmaceutics & drug disposition, 2000-09, Vol.21 (6), p.235-242

2000

Volltextzugriff (PDF)

PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID

Biopharmaceutics & drug disposition, 1996-10, Vol.17 (7), p.565-575

1996

Volltextzugriff (PDF)

Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid

Biopharmaceutics & drug disposition, 1993-01, Vol.14 (1), p.51-59

1993

Volltextzugriff (PDF)

Dual effect of valproic acid on the pharmacokinetics of phenytoin

Biopharmaceutics & drug disposition, 1993-05, Vol.14 (4), p.365-370

1993

Volltextzugriff (PDF)

Changes in uridine 5′‐diphospho‐glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acid

Biopharmaceutics & drug disposition, 2022-10, Vol.43 (5), p.175-182

2022

Volltextzugriff (PDF)

Applicability of the Øie‐Tozer model to predict three types of distribution volume (Vd) in humans: Vd in central compartment, Vd at steady state, and Vd at beta phase

Biopharmaceutics & drug disposition, 2020-04, Vol.41 (4-5), p.151-165

2020

Volltextzugriff (PDF)

Population pharmacokinetics of valproate in Mexican children with epilepsy

Biopharmaceutics & drug disposition, 2008-12, Vol.29 (9), p.511-520

2008

Volltextzugriff (PDF)

Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride

Biopharmaceutics & drug disposition, 2007-09, Vol.28 (6), p.331-338

2007

Volltextzugriff (PDF)

Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

Biopharmaceutics & drug disposition, 2004-11, Vol.25 (8), p.345-352

2004

Volltextzugriff (PDF)

The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulations

Biopharmaceutics & drug disposition, 2005-12, Vol.26 (9), p.417-425

2005

Volltextzugriff (PDF)

Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

Biopharmaceutics & drug disposition, 1999-07, Vol.20 (5), p.233-240

1999

Volltextzugriff (PDF)

Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers

Biopharmaceutics & drug disposition, 2004-11, Vol.25 (8), p.353-357

2004

Volltextzugriff (PDF)

Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding

Biopharmaceutics & drug disposition, 2001-09, Vol.22 (6), p.243-249

2001

Volltextzugriff (PDF)

Effect of infusion duration on valproate pharmacokinetics

Biopharmaceutics & drug disposition, 1993-07, Vol.14 (5), p.389-399

1993

Volltextzugriff (PDF)

Influence of food intake on the pharmacokinetics of a sustained release formulation of sodium valproate

Biopharmaceutics & drug disposition, 1993-08, Vol.14 (6), p.511-518

1993

Volltextzugriff (PDF)

EPILIM® CHRONO: A MULTIDOSE, CROSSOVER COMPARISON OF TWO FORMULATIONS OF VALPROATE IN HEALTHY VOLUNTEERS

Biopharmaceutics & drug disposition, 1996-03, Vol.17 (2), p.175-182

1996

Volltextzugriff (PDF)

Urinary excretion of valproate metabolites in children and adolescents

Biopharmaceutics & drug disposition, 2000-11, Vol.21 (8), p.327-330

2000

Volltextzugriff (PDF)

DOSE-DEPENDENT DISTRIBUTION VOLUMES OF TOTAL AND UNBOUND VALPROATE IN GUINEA-PIGS: CONSEQUENCE OF NON-LINEAR PLASMA PROTEIN BINDING

Biopharmaceutics & drug disposition, 1996-04, Vol.17 (3), p.237-247

1996

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid

Biopharmaceutics & drug disposition, 1993-05, Vol.14 (4), p.325-339

1993

Volltextzugriff (PDF)

Pharmacokinetic interaction between valproic acid and phenobarbital

Biopharmaceutics & drug disposition, 1993-01, Vol.14 (1), p.81-86

1993

Volltextzugriff (PDF)

Pharmacokinetics of valpromide in dogs after various modes of administration

Biopharmaceutics & drug disposition, 1984-04, Vol.5 (2), p.177-183

1984

Volltextzugriff (PDF)

Nonlinear elimination and hepatic concentration of conjugation- metabolite of valproate in guinea-pigs

Biopharmaceutics & drug disposition, 1993-05, Vol.14 (4), p.297-312

1993

Volltextzugriff (PDF)

Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirs

Biopharmaceutics & drug disposition, 1983-04, Vol.4 (2), p.173-182

1983

Volltextzugriff (PDF)

Pharmacokinetics of valproic acid in volunteers after a single dose study

Biopharmaceutics & drug disposition, 1985-01, Vol.6 (1), p.33-42

1985

Volltextzugriff (PDF)

Valproic acid and active unsaturated metabolite (2-EN): Transfer to mouse liver following human therapeutic doses

Biopharmaceutics & drug disposition, 1985-01, Vol.6 (1), p.1-8

1985

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SerieBiopharmaceutics & Drug Disposition

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Pharmacology & Pharmacy
(27)
Science & Technology
(27)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Pharmacology. Drug Treatments
(23)
Male
(21)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(20)
Neuropharmacology
(20)
Valproic Acid - Pharmacokinetics
(17)
Humans
(16)
Valproic Acid
(16)
Animals
(15)
Pharmacokinetics
(13)
Anticonvulsants - Pharmacokinetics
(12)
Female
(12)
Valproic Acid - Administration & Dosage
(12)
Valproic Acid - Metabolism
(11)
Adult
(10)
Kinetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Biopharmaceutics And Drug Disposition
(1)

Menü

Weitere Dienste

Einstellungen

Effect of naproxen co-administration on valproate disposition

PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID

Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid

Dual effect of valproic acid on the pharmacokinetics of phenytoin

Changes in uridine 5′‐diphospho‐glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acid

Applicability of the Øie‐Tozer model to predict three types of distribution volume (Vd) in humans: Vd in central compartment, Vd at steady state, and Vd at beta phase

Population pharmacokinetics of valproate in Mexican children with epilepsy

Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride

Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulations

Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers

Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding

Effect of infusion duration on valproate pharmacokinetics

Influence of food intake on the pharmacokinetics of a sustained release formulation of sodium valproate

EPILIM® CHRONO: A MULTIDOSE, CROSSOVER COMPARISON OF TWO FORMULATIONS OF VALPROATE IN HEALTHY VOLUNTEERS

Urinary excretion of valproate metabolites in children and adolescents

DOSE-DEPENDENT DISTRIBUTION VOLUMES OF TOTAL AND UNBOUND VALPROATE IN GUINEA-PIGS: CONSEQUENCE OF NON-LINEAR PLASMA PROTEIN BINDING

Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid

Pharmacokinetic interaction between valproic acid and phenobarbital

Pharmacokinetics of valpromide in dogs after various modes of administration

Nonlinear elimination and hepatic concentration of conjugation- metabolite of valproate in guinea-pigs

Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirs

Pharmacokinetics of valproic acid in volunteers after a single dose study

Valproic acid and active unsaturated metabolite (2-EN): Transfer to mouse liver following human therapeutic doses

Aktive Filter

Suchergebnisse filtern